Physical Activity Behavioral Change Intervention in Lung Cancer
RETOS
A Personalized Physical Activity Intervention and Behavioral Change in Lung Cancer Patients: RETOS Pilot Study
1 other identifier
interventional
40
1 country
1
Brief Summary
Patients with lung cancer have poor physical activity and increased sedentary behavior, with the presence of high levels of fatigue. A randomized controlled trial will be carried out to compare usual care versus a personalized exercise program in the community, in order to explore the changes on physical activity and sedentary behavior and its impact on cancer-related fatigue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable lung-cancer
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2023
CompletedFirst Posted
Study publicly available on registry
January 31, 2024
CompletedStudy Start
First participant enrolled
February 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedFebruary 9, 2024
February 1, 2024
1.3 years
September 8, 2023
February 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Physical Activity
Level of daily physical activity measured with accelerometry. Accelerometry will be worn by patients for 7 consecutive days and will measure the time in minutes spent in low (1.6 - \<3 METs), moderate (3.0 - \<6.0 METs) and vigorous (⩾6 METs) physical activities.
7 consecutive days, before and after intervention (6 months)
Sedentarism
Weekly sedentary behavior measured with the Sedentary Behaviour Questionnaire (SBQ). The SBQ measures the time in minutes spent in 9 different sedentary activities during a week, differentiating working days and week-ends. The score is the separately sum of the hours per day for week days and week-end days. A higher score is indicative of longer time spent in sitting and therefore an indication of higher sedentarism.
Before and after intervention (6 months)
Secondary Outcomes (12)
Walking distance
Before and after intervention (6 months)
1-minute Sit-to-Stand test
Before and after intervention (6 months)
Pulmonary function
Before and after intervention (6 months)
Dyspnea
Before and after intervention (6 months), and once a week during intervention.
Cancer Quality of Life Questionnaire
Before and after intervention (6 months).
- +7 more secondary outcomes
Other Outcomes (2)
Daily dyspnea
Before and after each physical activity session, minimum 3 sessions per week, during the intervention period (6 months).
Steps per day
Once a week during intervention (6 months)
Study Arms (2)
Control Group
ACTIVE COMPARATORThe control group will follow the conventional protocol established by the Catalan Institute of Oncology (ICO) for the treatment of lung cancer. In addition, physical activity guidelines will be recommended with the aim of encouraging patients to lead a more active life that helps them improve their physical capabilities. The research team will meet individually with participants in the control group and inform them about the importance of physical activity, motivating them to practice regularly.
Experimental Group
EXPERIMENTALMotivational interviews will be used to help identify individual motivations, barriers, and preferences towards physical activity (PA). Objectives and personalized exercise regimens (e.g. walking, cycling, nordic walking) with a person-centered approach. Patients will engage in a minimum of 3 PA sessions/week (45min each) for 6 months, reporting via a phone app. Weekly patient-reported outcome measures (PROMs) will track progress. The first 3 months involve group sessions for instruction and correction; the last 3 months include one monthly in-person session combining resistance and aerobic training, with a duration of 1.5 hours. To drive behavior change, personalized weekly challenges will be presented.
Interventions
Supervised and guided PA sessions in the community setting using public resources such as parks, sports facilities, etc.
Conventional protocol for lung cancer and PA recommendations.
Eligibility Criteria
You may qualify if:
- patients with a diagnosis of non-small cell lung cancer who are candidates for radical and/or metastatic treatment
- ages between 18 and 70
- ability to answer questionnaires in Spanish
- who have accepted participation and signed the informed consent
You may not qualify if:
- participants with a life expectancy of less than 6 months
- patients with levels of physical activity greater than 240 metabolic equivalents (MET) METs/day
- patients who have a contraindication to exercise
- patients with dementia or spatial disorientation or behavioral disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ramon Llulllead
- Institut Català d'Oncologiacollaborator
Study Sites (1)
Blanquerna Health Science Faculty
Barcelona, 08025, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jordi Teixido, PhD
University Ramon Llull
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The investigator and the professional who will do the statistical analyses, will be blinded to the group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2023
First Posted
January 31, 2024
Study Start
February 15, 2024
Primary Completion
May 31, 2025
Study Completion
October 31, 2025
Last Updated
February 9, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share